Marlieke EA de Kraker
Biographic Data
| ID | 9006749 |
|---|---|
| NAME | Marlieke EA de Kraker |
| GIVEN NAMES | Marlieke EA |
| FAMILY NAME | de Kraker |
| SIGNATURE | DE KRAKER M E |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2025 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Reserve antibiotics
New antibiotics active against multidrug resistant bacteria (MDR-B) are licensed by regulatory agencies based on pivotal trials that serve the primary purpose of obtaining marketing-authorization. There is increasing concern that they do not offer guidance on how to best use new antibiotics, in which population, and to what extent they overcome existing resistance. We reviewed the literature for pre-approval studies (phase 2 and 3 randomized cont…
No prominent works on this page.
Reserve antibiotics
New antibiotics active against multidrug resistant bacteria (MDR-B) are licensed by regulatory agencies based on pivotal trials that serve the primary purpose of obtaining marketing-authorization. There is increasing concern that they do not offer guidance on how to best use new antibiotics, in which population, and to what extent they overcome existing resistance. We reviewed the literature for pre-approval studies (phase 2 and 3 randomized cont…
Antibiotic Resistance in Bacteria (1 work) · Antibiotic Use and Resistance (1 work) · Antibiotics Pharmacokinetics and Efficacy (1 work) · Bioinformatics (1 work) · Biology (1 work) · Business (1 work) · Clinical trial (1 work) · Environmental health (1 work) · European union (1 work) · Intensive care medicine (1 work)